Comparing Two Forms of Head Immobilization for Stereotactic Radiotherapy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00328510 |
|
Recruitment Status :
Completed
First Posted : May 22, 2006
Results First Posted : August 19, 2013
Last Update Posted : November 29, 2016
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Patients Receiving Fractionated Stereotactic Radiotherapy for Brain Tumors | Device: GTC frame Device: Thermoplastic facemask Radiation: Stereotactic radiation therapy | Phase 3 |
PRIMARY OBJECTIVE:
1) To compare the efficacy of two commonly used, generally accepted forms of immobilization for the treatment of lesions in the head with fractionated stereotactic radiotherapy. Specifically, this study will use the ExacTRAC kilovoltage imaging system to assess positioning accuracy for these two systems.
OUTLINE:
Two routinely used methods of immobilization, which differ in their approach to reproduce head position from day-to-day are the Gill-Thomas-Cosman (GTC)frame and the BrainLab thermoplastic mask. The GTC frame fixates on the patient upper detention and thus us in direct mechanical contact with the cranium. The BrainLab mask is a two-part masking system custom-fitted to the front and back of the participant's head. After patients sign an IRB-approved informed consent form, eligible participants are either randomized to either the GTC frame or the mask for their course of SRT. Participants are treated as per standard procedure; however, prior to each treatment, a set of digital kV images (ExacTrac, BrainLabAB, Germany) is taken. These images are fused with reference digitally constructed radiographs obtained from treatment planning CT to yield lateral, longitudinal, and vertical deviations of isocenter and head rotations about respective axes. The primary endpoint of the study is to compare the two systems with respect to mean and standard deviations (SDs) using the distance to isocenter measure.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 83 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | A Randomized Trial Comparing Two Forms of Immobilization of the Head for Fractioned Stereotactic Radiotherapy |
| Study Start Date : | February 2005 |
| Actual Primary Completion Date : | January 2008 |
| Actual Study Completion Date : | September 2009 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: GTC Frame
Participant undergoes SRT using a GTC frame to immobilize the participant's heading during radiation therapy
|
Device: GTC frame Radiation: Stereotactic radiation therapy Other Name: SRT |
|
Experimental: BrainLab thermoplastic mask
Participant undergoes SRT using the BrainLab thermoplastic mask to immobilize the participant's head during radiation therapy
|
Device: Thermoplastic facemask Radiation: Stereotactic radiation therapy Other Name: SRT |
- Distance From Ideal to Center of GTC Frame and BrainLab Thermoplastic Mask With Respect to Average and Variability [ Time Frame: Measurements taken during SRT ]This study uses the ExacTRAC imaging system to assess positioning of frame or mask during SRT. Images yield lateral, longitudinal, and vertical deviations of the isocenter as well as head rotations about respective axes.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients who are eligible for fractionated stereotactic radiotherapy
Exclusion Criteria:
- Severe claustrophobia
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00328510
| United States, Pennsylvania | |
| Thomas Jefferson University Hospital | |
| Philadelphia, Pennsylvania, United States, 19107 | |
| Principal Investigator: | Maria Werner-Wasik, MD | Thomas Jefferson University |
Publications:
| Responsible Party: | Sidney Kimmel Cancer Center at Thomas Jefferson University |
| ClinicalTrials.gov Identifier: | NCT00328510 |
| Other Study ID Numbers: |
04U.534 2004-72 ( Other Identifier: CCRRC ) |
| First Posted: | May 22, 2006 Key Record Dates |
| Results First Posted: | August 19, 2013 |
| Last Update Posted: | November 29, 2016 |
| Last Verified: | October 2016 |
|
Stereotactic radiotherapy |
|
Brain Neoplasms Central Nervous System Neoplasms Nervous System Neoplasms Neoplasms by Site |
Neoplasms Brain Diseases Central Nervous System Diseases Nervous System Diseases |

